A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis
Clinical trial NCT01730248 · TERMINATED
Trial details
- NCT number
- NCT01730248
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-18
- Primary completion
- 2017-09-28
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.